Skip to main content

Table 4 Total costs used in the model a

From: Long-term cost effectiveness of ticagrelor in patients with acute coronary syndromes in Thailand

Items Cost (THB) Sources
One-year decision tree   
Ticagrelor   
Annual drug cost 34,368 Manufacturer’s price
No event 117,404 Nikolic [8], Riewpaiboon [16]
Non-fatal MI 204,851 Nikolic [8], Riewpaiboon [16], Central office for Healthcare Information [17]
Non-fatal stroke 141,918 Nikolic [8], Riewpaiboon [16]
Death any cause 120,132 Nikolic [8], Riewpaiboon [16]
Clopidogrel   
Annual drug cost (branded price) 26,473 DMSIC [17]
Annual drug cost (generic price) 344 DMSIC [17]
No event 120,307 Nikolic [8], Riewpaiboon [16]
Non-fatal MI 207,753 Nikolic [8], Riewpaiboon [16], Central office for Healthcare Information [17]
Non-fatal stroke 144,821 Nikolic [8], Riewpaiboon [16]
Death any cause 123,034 Nikolic [8], Riewpaiboon [16]
Markov model   
Total cost MI 1st year Markov model 168,196 Anukoolsawat [4]
Total cost MI 2nd year and onward 35,926 Anukoolsawat [4]
Total cost stroke 1st year Markov model 79,800 Tamteeranon [15]
Total cost stroke 2nd year and onward 12,642 Tamteeranon [15]
Total cost of no event 21,866 Anukoolsawat [4]
  1. aDetailed table of Thai hospital charges and unit cost (Baht) for the resource use collected in the PLATO trial provided in the Additional file 1: Table S1.